These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 1339603)

  • 1. [A program for prevention of pseudomonas infections and immunoprophylaxis with PSAEVA vaccine].
    Kahlich R; Vojtísková J; Táborský J; Sedlácková E; Liska M; Pechancová J; Totusek P
    Cesk Epidemiol Mikrobiol Imunol; 1992 Sep; 42(3):120-5. PubMed ID: 1339603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunomodulation in Pseudomonas urinary infection].
    Urban M; Tamele L
    Rozhl Chir; 1995 Nov; 74(7):319-21. PubMed ID: 8629153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccine strategies against Pseudomonas aeruginosa infection in the lung.
    Cripps AW; Dunkley ML; Clancy RL; Kyd J
    Behring Inst Mitt; 1997 Feb; (98):262-8. PubMed ID: 9382749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical use of a Soviet polyvalent corpuscular pyocyanic vaccine for the prevention of Pseudomonas aeruginosa infection in thermal burn victims].
    Gerasimova LI; Moroz AF; Radkevich SA; Sveshnikov AI; Mizikin EV
    Khirurgiia (Mosk); 1980 Nov; (11):36-41. PubMed ID: 6777578
    [No Abstract]   [Full Text] [Related]  

  • 5. Application of vaccine technology to prevention of Pseudomonas aeruginosa infections.
    Pier G
    Expert Rev Vaccines; 2005 Oct; 4(5):645-56. PubMed ID: 16221066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylaxis and therapy of Pseudomonas aeruginosa infection in cystic fibrosis and immunocompromised patients.
    Lang AB; Horn MP; Imboden MA; Zuercher AW
    Vaccine; 2004 Dec; 22 Suppl 1():S44-8. PubMed ID: 15576201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of pseudomonas respiratory infection in a surgical intensive care unit.
    Polk HC; Borden S; Aldrete JA
    Ann Surg; 1973 May; 177(5):607-15. PubMed ID: 4634109
    [No Abstract]   [Full Text] [Related]  

  • 8. Vaccines against Pseudomonas aeruginosa results and perspectives of investigations (survey).
    Joó I; Stanislavskii ES
    J Hyg Epidemiol Microbiol Immunol; 1982; 26(4):417-27. PubMed ID: 6819316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Nosocomial infections caused by Pseudomonas aeruginosa: Exogenous or endogenous origin of this bacterium?].
    Floret N; Bertrand X; Thouverez M; Talon D
    Pathol Biol (Paris); 2009 Feb; 57(1):9-12. PubMed ID: 18848405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pseudomonas aeruginosa: prevention better than cure?
    Mellor JA; Miler JJ
    Dev Biol Stand; 1979; 43():53-9. PubMed ID: 118071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthetic peptide vaccine and antibody therapeutic development: prevention and treatment of Pseudomonas aeruginosa.
    Cachia PJ; Hodges RS
    Biopolymers; 2003; 71(2):141-68. PubMed ID: 12767116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Possibilities and prospects of immunoprophylaxis and immunotherapy of pyocyanic infections under supervision of these infections using epidemiological markers].
    Meitert E; Meitert T
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1983; 32(4):289-302. PubMed ID: 6320334
    [No Abstract]   [Full Text] [Related]  

  • 13. [Epidemiology of nosocomial infections due to Pseudomonas aeruginosa, Burkholderia cepacia and Stenotrophomonas maltophilia].
    Berthelot P; Grattard F; Mallaval FO; Ros A; Lucht F; Pozzetto B
    Pathol Biol (Paris); 2005 Jul; 53(6):341-8. PubMed ID: 16004946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccines and immunotherapy against Pseudomonas aeruginosa.
    Döring G; Pier GB
    Vaccine; 2008 Feb; 26(8):1011-24. PubMed ID: 18242792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic generation of antigen specific human monoclonal antibodies with therapeutical activities using active immunization.
    Lang AB; Fürer E; Senyk G; Larrick JW; Cryz SJ
    Hum Antibodies Hybridomas; 1990; 1(2):96-103. PubMed ID: 2129420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Results of using polyvalent Pseudomonas aeruginosa vaccine in children with burns by various medical centers].
    Bbukowska D; Serafińska D; Rudowski W; Hoffman S; Olański W; Gardzińska E; Popiel D; Jedrzejczak G; Czarnecka I
    Pol Tyg Lek; 1989 Oct 23-Nov 6; 44(43-45):924-7. PubMed ID: 2518666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation measures for prevention of infection with respiratory pathogens in cystic fibrosis: a systematic review?
    Høiby N; Johansen HK
    J Hosp Infect; 2007 Apr; 65(4):374-5; author reply 375-6. PubMed ID: 17275952
    [No Abstract]   [Full Text] [Related]  

  • 18. Pseudomonas aeruginosa. Vaccines and immunotherapy.
    Pennington JE
    Infect Dis Clin North Am; 1990 Jun; 4(2):259-70. PubMed ID: 2111838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multicenter vaccine trial using the Pseudomonas aeruginosa flagella vaccine IMMUNO in patients with cystic fibrosis.
    Döring G; Dorner F
    Behring Inst Mitt; 1997 Feb; (98):338-44. PubMed ID: 9382758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapy of nosocomial infections: past, present and future trends.
    Pasko M; Beam TR
    J Med; 1980; 11(4):303-15. PubMed ID: 6943262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.